| Product Code: ETC7538956 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
India`s CIS insulin import shipments in 2024 saw a notable shift in the top exporting countries, with Australia, USA, South Korea, Germany, and New Zealand leading the pack. The Herfindahl-Hirschman Index (HHI) indicated a significant decrease in market concentration from 2023 to 2024, moving from high to moderate concentration. The compound annual growth rate (CAGR) from 2020 to 2024 was -14.84%, reflecting a declining trend, while the growth rate for 2023 to 2024 saw a sharp decline of -48.07%. These trends suggest a dynamic and evolving landscape in the Indian CIS insulin market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India CIS Insulin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 India CIS Insulin Market - Industry Life Cycle |
3.4 India CIS Insulin Market - Porter's Five Forces |
3.5 India CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 India CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 India CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 India CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in India and CIS countries |
4.2.2 Growing awareness about diabetes management and treatment options |
4.2.3 Technological advancements in insulin delivery systems |
4.2.4 Rising healthcare expenditure in the region |
4.2.5 Favorable government initiatives and policies supporting diabetes care |
4.3 Market Restraints |
4.3.1 High cost of insulin therapy |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Cultural beliefs and practices affecting diabetes management |
4.3.4 Lack of skilled healthcare professionals specialized in diabetes care |
4.3.5 Potential side effects and complications associated with insulin therapy |
5 India CIS Insulin Market Trends |
6 India CIS Insulin Market, By Types |
6.1 India CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 India CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 India CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 India CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 India CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 India CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 India CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 India CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 India CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 India CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 India CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 India CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 India CIS Insulin Market Import-Export Trade Statistics |
7.1 India CIS Insulin Market Export to Major Countries |
7.2 India CIS Insulin Market Imports from Major Countries |
8 India CIS Insulin Market Key Performance Indicators |
8.1 Average HbA1c levels in the target population |
8.2 Adoption rate of advanced insulin delivery systems |
8.3 Number of diabetes education programs conducted in the region |
8.4 Percentage of diabetic patients regularly monitoring blood glucose levels |
8.5 Rate of complications and hospitalizations related to diabetes |
9 India CIS Insulin Market - Opportunity Assessment |
9.1 India CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 India CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 India CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 India CIS Insulin Market - Competitive Landscape |
10.1 India CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 India CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here